Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04986423
Title ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate Cancer
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Zenith Epigenetics
Indications

prostate cancer

Therapies

Enzalutamide + ZEN-3694

Enzalutamide

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.